Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Celiac Disease | 50 | 2023 | 203 | 12.910 |
Why?
|
Probiotics | 17 | 2022 | 81 | 3.910 |
Why?
|
Glutens | 20 | 2022 | 76 | 3.770 |
Why?
|
Diet, Gluten-Free | 17 | 2022 | 52 | 3.080 |
Why?
|
Diarrhea | 9 | 2020 | 182 | 2.540 |
Why?
|
Gastrointestinal Diseases | 8 | 2017 | 146 | 1.610 |
Why?
|
Food Hypersensitivity | 5 | 2018 | 63 | 1.590 |
Why?
|
Transglutaminases | 9 | 2023 | 39 | 1.520 |
Why?
|
Child | 35 | 2023 | 6927 | 1.480 |
Why?
|
Immunoglobulin A | 5 | 2023 | 80 | 1.450 |
Why?
|
Irritable Bowel Syndrome | 5 | 2020 | 45 | 1.250 |
Why?
|
Autoantibodies | 8 | 2019 | 267 | 1.220 |
Why?
|
Triticum | 3 | 2017 | 32 | 1.160 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2023 | 567 | 1.130 |
Why?
|
Child, Preschool | 17 | 2020 | 3612 | 0.940 |
Why?
|
Gastroenteritis | 2 | 2015 | 27 | 0.860 |
Why?
|
Duodenum | 5 | 2022 | 100 | 0.840 |
Why?
|
HLA-DQ Antigens | 4 | 2019 | 52 | 0.840 |
Why?
|
Humans | 79 | 2023 | 86644 | 0.830 |
Why?
|
Gastroenterology | 6 | 2019 | 134 | 0.820 |
Why?
|
Abdominal Pain | 3 | 2020 | 137 | 0.790 |
Why?
|
Infant | 17 | 2020 | 3047 | 0.790 |
Why?
|
Oryza | 2 | 2018 | 40 | 0.780 |
Why?
|
Constipation | 2 | 2020 | 63 | 0.770 |
Why?
|
Practice Guidelines as Topic | 7 | 2019 | 1036 | 0.750 |
Why?
|
Adolescent | 20 | 2020 | 8981 | 0.740 |
Why?
|
Biopsy | 9 | 2023 | 1163 | 0.730 |
Why?
|
Blood Chemical Analysis | 1 | 2019 | 42 | 0.700 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2019 | 376 | 0.700 |
Why?
|
Eosinophilic Esophagitis | 1 | 2019 | 18 | 0.690 |
Why?
|
Weaning | 4 | 2016 | 25 | 0.690 |
Why?
|
Automation | 1 | 2019 | 106 | 0.680 |
Why?
|
Gliadin | 3 | 2016 | 17 | 0.650 |
Why?
|
Wheat Hypersensitivity | 2 | 2017 | 4 | 0.650 |
Why?
|
Egg Yolk | 1 | 2017 | 4 | 0.610 |
Why?
|
Enterocolitis, Necrotizing | 4 | 2015 | 78 | 0.610 |
Why?
|
Diagnosis, Differential | 4 | 2020 | 1565 | 0.600 |
Why?
|
Beer | 1 | 2016 | 1 | 0.600 |
Why?
|
Direct Service Costs | 1 | 2016 | 3 | 0.580 |
Why?
|
Infant Nutritional Physiological Phenomena | 2 | 2007 | 19 | 0.570 |
Why?
|
Crohn Disease | 5 | 2019 | 730 | 0.560 |
Why?
|
Lactobacillus | 5 | 2011 | 21 | 0.540 |
Why?
|
Health Status | 2 | 2011 | 360 | 0.540 |
Why?
|
Breast Feeding | 5 | 2016 | 91 | 0.540 |
Why?
|
Diet, Mediterranean | 1 | 2015 | 6 | 0.520 |
Why?
|
Ambulatory Care | 1 | 2016 | 181 | 0.510 |
Why?
|
Immunoglobulin G | 1 | 2016 | 456 | 0.500 |
Why?
|
Inflammatory Bowel Diseases | 4 | 2019 | 549 | 0.500 |
Why?
|
Intestinal Mucosa | 10 | 2022 | 797 | 0.470 |
Why?
|
Autoimmunity | 3 | 2010 | 160 | 0.450 |
Why?
|
Infant, Newborn | 8 | 2020 | 2380 | 0.450 |
Why?
|
Treatment Outcome | 13 | 2019 | 7993 | 0.440 |
Why?
|
Diet | 3 | 2017 | 443 | 0.430 |
Why?
|
Hospitalization | 2 | 2016 | 849 | 0.430 |
Why?
|
GTP-Binding Proteins | 4 | 2020 | 146 | 0.430 |
Why?
|
Food | 1 | 2011 | 86 | 0.390 |
Why?
|
Health Care Surveys | 1 | 2012 | 278 | 0.390 |
Why?
|
Fetal Development | 1 | 2011 | 30 | 0.390 |
Why?
|
T-Lymphocytes, Cytotoxic | 4 | 2015 | 315 | 0.380 |
Why?
|
Guideline Adherence | 1 | 2012 | 223 | 0.360 |
Why?
|
Remission Induction | 4 | 2018 | 722 | 0.360 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2015 | 865 | 0.360 |
Why?
|
Genetic Predisposition to Disease | 7 | 2019 | 2271 | 0.360 |
Why?
|
Intestine, Small | 4 | 2016 | 303 | 0.350 |
Why?
|
Male | 24 | 2022 | 40966 | 0.350 |
Why?
|
Child Development | 1 | 2011 | 164 | 0.340 |
Why?
|
Adult | 16 | 2019 | 25648 | 0.340 |
Why?
|
Child Nutrition Sciences | 2 | 2018 | 2 | 0.330 |
Why?
|
Colitis, Ulcerative | 2 | 2019 | 711 | 0.330 |
Why?
|
Rotavirus Infections | 1 | 2008 | 12 | 0.320 |
Why?
|
Colon | 3 | 2011 | 496 | 0.320 |
Why?
|
Female | 22 | 2020 | 44533 | 0.310 |
Why?
|
Immunologic Factors | 1 | 2008 | 170 | 0.300 |
Why?
|
Inflammation | 3 | 2019 | 920 | 0.300 |
Why?
|
Societies, Medical | 4 | 2018 | 572 | 0.290 |
Why?
|
Milk, Human | 1 | 2007 | 43 | 0.290 |
Why?
|
Cross Infection | 4 | 2011 | 141 | 0.290 |
Why?
|
Retrospective Studies | 8 | 2020 | 8489 | 0.290 |
Why?
|
Endoscopy, Gastrointestinal | 2 | 2018 | 153 | 0.280 |
Why?
|
Anti-Bacterial Agents | 4 | 2015 | 746 | 0.280 |
Why?
|
Bifidobacterium | 3 | 2011 | 16 | 0.280 |
Why?
|
Colonic Diseases | 1 | 2016 | 65 | 0.280 |
Why?
|
Environmental Exposure | 1 | 2008 | 296 | 0.280 |
Why?
|
Risk Factors | 10 | 2018 | 5417 | 0.270 |
Why?
|
Infant Formula | 1 | 2005 | 17 | 0.270 |
Why?
|
Health Care Reform | 1 | 2016 | 90 | 0.260 |
Why?
|
Colectomy | 1 | 2016 | 167 | 0.260 |
Why?
|
Respiratory Tract Infections | 1 | 2006 | 105 | 0.260 |
Why?
|
Antibodies | 2 | 2019 | 350 | 0.240 |
Why?
|
Physicians | 1 | 2012 | 673 | 0.240 |
Why?
|
Interleukin-15 | 3 | 2015 | 72 | 0.240 |
Why?
|
Saccharomyces | 2 | 2015 | 21 | 0.240 |
Why?
|
Women's Health | 1 | 2005 | 100 | 0.240 |
Why?
|
Double-Blind Method | 4 | 2018 | 1823 | 0.240 |
Why?
|
Cross-Over Studies | 2 | 2018 | 399 | 0.240 |
Why?
|
Emergency Medical Services | 1 | 2016 | 209 | 0.240 |
Why?
|
Pediatrics | 2 | 2018 | 344 | 0.240 |
Why?
|
Evidence-Based Medicine | 4 | 2016 | 429 | 0.230 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 2 | 2015 | 29 | 0.220 |
Why?
|
Predictive Value of Tests | 4 | 2019 | 1673 | 0.220 |
Why?
|
Acute Disease | 4 | 2008 | 826 | 0.220 |
Why?
|
Disulfides | 1 | 2022 | 64 | 0.210 |
Why?
|
Genetic Testing | 2 | 2019 | 535 | 0.210 |
Why?
|
Thiorphan | 1 | 2002 | 5 | 0.210 |
Why?
|
Comorbidity | 2 | 2016 | 943 | 0.210 |
Why?
|
Severity of Illness Index | 2 | 2018 | 1801 | 0.210 |
Why?
|
Meta-Analysis as Topic | 2 | 2015 | 87 | 0.200 |
Why?
|
Cohort Studies | 2 | 2019 | 2767 | 0.200 |
Why?
|
Insurance, Health | 2 | 2016 | 160 | 0.200 |
Why?
|
Practice Patterns, Physicians' | 1 | 2016 | 582 | 0.200 |
Why?
|
Intestines | 3 | 2019 | 411 | 0.190 |
Why?
|
Aging | 1 | 2005 | 691 | 0.190 |
Why?
|
Environment | 2 | 2014 | 219 | 0.190 |
Why?
|
Time Factors | 5 | 2018 | 5210 | 0.190 |
Why?
|
Child Day Care Centers | 2 | 2011 | 6 | 0.190 |
Why?
|
Health Care Costs | 2 | 2016 | 238 | 0.180 |
Why?
|
Laxatives | 1 | 2020 | 13 | 0.180 |
Why?
|
Quality of Life | 3 | 2016 | 1585 | 0.180 |
Why?
|
Antigens | 2 | 2019 | 228 | 0.180 |
Why?
|
Risk Assessment | 4 | 2016 | 2261 | 0.170 |
Why?
|
Th1 Cells | 2 | 2017 | 164 | 0.170 |
Why?
|
Body Mass Index | 2 | 2020 | 770 | 0.170 |
Why?
|
Starch | 1 | 2018 | 8 | 0.170 |
Why?
|
Age Factors | 2 | 2018 | 1851 | 0.160 |
Why?
|
Pathology, Clinical | 1 | 2018 | 33 | 0.160 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2019 | 102 | 0.160 |
Why?
|
Polyethylene Glycols | 1 | 2020 | 363 | 0.150 |
Why?
|
Middle Aged | 7 | 2019 | 25028 | 0.150 |
Why?
|
Young Adult | 3 | 2019 | 5976 | 0.150 |
Why?
|
Prevalence | 3 | 2020 | 1239 | 0.150 |
Why?
|
Prognosis | 3 | 2016 | 3679 | 0.150 |
Why?
|
Animals | 9 | 2022 | 26582 | 0.150 |
Why?
|
Reoviridae Infections | 1 | 2017 | 7 | 0.150 |
Why?
|
Europe | 3 | 2018 | 309 | 0.150 |
Why?
|
Flour | 1 | 2016 | 2 | 0.150 |
Why?
|
Case-Control Studies | 3 | 2016 | 1805 | 0.150 |
Why?
|
Interprofessional Relations | 1 | 2018 | 121 | 0.150 |
Why?
|
Sorghum | 1 | 2016 | 4 | 0.150 |
Why?
|
Hordeum | 1 | 2016 | 10 | 0.150 |
Why?
|
Feeding Behavior | 2 | 2020 | 324 | 0.150 |
Why?
|
Internationality | 1 | 2016 | 69 | 0.140 |
Why?
|
Sex Distribution | 1 | 2016 | 173 | 0.140 |
Why?
|
Leadership | 1 | 2018 | 134 | 0.140 |
Why?
|
Age Distribution | 1 | 2016 | 204 | 0.140 |
Why?
|
Antibody Formation | 1 | 2016 | 171 | 0.140 |
Why?
|
Allergens | 1 | 2017 | 179 | 0.140 |
Why?
|
Costs and Cost Analysis | 1 | 2016 | 153 | 0.140 |
Why?
|
Infant, Premature | 2 | 2015 | 290 | 0.140 |
Why?
|
Peptides | 1 | 2019 | 639 | 0.140 |
Why?
|
Databases, Factual | 1 | 2019 | 814 | 0.140 |
Why?
|
Leukotrienes | 1 | 2015 | 20 | 0.140 |
Why?
|
Immunoglobulin E | 2 | 2017 | 144 | 0.130 |
Why?
|
Attitude | 1 | 2016 | 127 | 0.130 |
Why?
|
Cross-Sectional Studies | 2 | 2020 | 1621 | 0.130 |
Why?
|
Reference Values | 1 | 2016 | 674 | 0.130 |
Why?
|
Adolescent Health | 1 | 2014 | 5 | 0.130 |
Why?
|
Cysteine | 1 | 2015 | 135 | 0.130 |
Why?
|
Cell Communication | 1 | 2015 | 194 | 0.120 |
Why?
|
Dietary Supplements | 2 | 2016 | 128 | 0.120 |
Why?
|
Adaptive Immunity | 1 | 2015 | 164 | 0.120 |
Why?
|
United States | 5 | 2016 | 6672 | 0.120 |
Why?
|
Mentors | 1 | 2014 | 76 | 0.120 |
Why?
|
Global Health | 1 | 2015 | 193 | 0.120 |
Why?
|
Stress, Physiological | 1 | 2015 | 227 | 0.110 |
Why?
|
Epithelial Cells | 2 | 2015 | 669 | 0.110 |
Why?
|
Feces | 2 | 2011 | 319 | 0.110 |
Why?
|
Faculty, Medical | 1 | 2014 | 178 | 0.110 |
Why?
|
Endoscopy, Digestive System | 1 | 2012 | 65 | 0.110 |
Why?
|
History, 21st Century | 3 | 2018 | 175 | 0.100 |
Why?
|
Fluid Therapy | 2 | 2002 | 50 | 0.100 |
Why?
|
History, 20th Century | 3 | 2018 | 312 | 0.100 |
Why?
|
Mass Screening | 2 | 2014 | 618 | 0.100 |
Why?
|
Community-Acquired Infections | 1 | 2011 | 63 | 0.100 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2011 | 3 | 0.100 |
Why?
|
Surveys and Questionnaires | 3 | 2019 | 2501 | 0.100 |
Why?
|
Prospective Studies | 1 | 2019 | 4214 | 0.100 |
Why?
|
Tight Junctions | 1 | 2011 | 149 | 0.090 |
Why?
|
Incidence | 1 | 2015 | 1577 | 0.090 |
Why?
|
Infant, Premature, Diseases | 1 | 2010 | 78 | 0.090 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2010 | 125 | 0.090 |
Why?
|
Disease Management | 1 | 2012 | 327 | 0.090 |
Why?
|
Phospholipases A2, Cytosolic | 1 | 2009 | 4 | 0.090 |
Why?
|
Family | 1 | 2010 | 311 | 0.080 |
Why?
|
Biological Products | 1 | 2010 | 143 | 0.080 |
Why?
|
Diet Therapy | 1 | 2008 | 20 | 0.080 |
Why?
|
Disease Models, Animal | 2 | 2017 | 2232 | 0.080 |
Why?
|
Italy | 2 | 2020 | 106 | 0.080 |
Why?
|
Rats, Wistar | 2 | 2022 | 297 | 0.080 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2008 | 158 | 0.070 |
Why?
|
Infant Food | 1 | 2007 | 11 | 0.070 |
Why?
|
Massachusetts | 1 | 2016 | 33 | 0.070 |
Why?
|
Immune System | 1 | 2008 | 93 | 0.070 |
Why?
|
Dysentery | 1 | 2006 | 3 | 0.070 |
Why?
|
Helicobacter Infections | 1 | 2006 | 34 | 0.070 |
Why?
|
Nutritional Requirements | 1 | 2005 | 17 | 0.070 |
Why?
|
Helicobacter pylori | 1 | 2006 | 35 | 0.070 |
Why?
|
Consumer Product Safety | 1 | 2005 | 11 | 0.070 |
Why?
|
Pyloric Stenosis | 1 | 2005 | 8 | 0.070 |
Why?
|
Serologic Tests | 2 | 2005 | 41 | 0.070 |
Why?
|
Professional-Patient Relations | 1 | 2005 | 53 | 0.060 |
Why?
|
Models, Genetic | 1 | 2010 | 926 | 0.060 |
Why?
|
Biomarkers | 2 | 2022 | 1718 | 0.060 |
Why?
|
Killer Cells, Natural | 1 | 2006 | 267 | 0.060 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 567 | 0.060 |
Why?
|
Signal Transduction | 3 | 2015 | 3241 | 0.060 |
Why?
|
Developmental Disabilities | 1 | 2005 | 195 | 0.060 |
Why?
|
Pregnancy | 1 | 2011 | 2894 | 0.060 |
Why?
|
School Nursing | 1 | 2003 | 4 | 0.060 |
Why?
|
Obesity | 2 | 2020 | 963 | 0.060 |
Why?
|
Immunotherapy | 1 | 2008 | 629 | 0.050 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2019 | 372 | 0.050 |
Why?
|
Diarrhea, Infantile | 1 | 2002 | 2 | 0.050 |
Why?
|
Multicenter Studies as Topic | 1 | 2002 | 159 | 0.050 |
Why?
|
Child Nutritional Physiological Phenomena | 1 | 2002 | 12 | 0.050 |
Why?
|
Sulfhydryl Compounds | 1 | 2022 | 69 | 0.050 |
Why?
|
Antidiarrheals | 1 | 2002 | 14 | 0.050 |
Why?
|
Developed Countries | 1 | 2002 | 24 | 0.050 |
Why?
|
Diagnostic Techniques, Digestive System | 1 | 2001 | 1 | 0.050 |
Why?
|
Aged | 3 | 2017 | 18415 | 0.050 |
Why?
|
Protease Inhibitors | 1 | 2002 | 72 | 0.050 |
Why?
|
Rats | 2 | 2022 | 3990 | 0.050 |
Why?
|
Developing Countries | 1 | 2002 | 71 | 0.050 |
Why?
|
Primary Prevention | 1 | 2002 | 85 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2018 | 3640 | 0.050 |
Why?
|
Chronic Disease | 2 | 2019 | 971 | 0.050 |
Why?
|
Nutritional Status | 1 | 2020 | 83 | 0.050 |
Why?
|
Homeostasis | 1 | 2022 | 409 | 0.050 |
Why?
|
Thinness | 1 | 2020 | 43 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2006 | 1578 | 0.050 |
Why?
|
Up-Regulation | 2 | 2015 | 712 | 0.040 |
Why?
|
Cell Differentiation | 1 | 2006 | 1458 | 0.040 |
Why?
|
Pilot Projects | 1 | 2002 | 839 | 0.040 |
Why?
|
Starvation | 1 | 1999 | 23 | 0.040 |
Why?
|
Cecum | 1 | 1999 | 68 | 0.040 |
Why?
|
Bacterial Adhesion | 1 | 1999 | 84 | 0.040 |
Why?
|
Oxidative Stress | 1 | 2022 | 447 | 0.040 |
Why?
|
Intestinal Absorption | 1 | 2019 | 124 | 0.040 |
Why?
|
Overweight | 1 | 2020 | 118 | 0.040 |
Why?
|
Butyrophilins | 1 | 2019 | 22 | 0.040 |
Why?
|
Intraepithelial Lymphocytes | 1 | 2019 | 16 | 0.040 |
Why?
|
Body Weight | 1 | 2020 | 459 | 0.040 |
Why?
|
Anniversaries and Special Events | 1 | 2018 | 14 | 0.040 |
Why?
|
North America | 1 | 2018 | 180 | 0.040 |
Why?
|
Reoviridae | 1 | 2017 | 6 | 0.040 |
Why?
|
Interferon Regulatory Factor-1 | 1 | 2017 | 19 | 0.040 |
Why?
|
Receptor, Interferon alpha-beta | 1 | 2017 | 20 | 0.040 |
Why?
|
Congresses as Topic | 1 | 2018 | 116 | 0.040 |
Why?
|
HEK293 Cells | 1 | 2019 | 615 | 0.040 |
Why?
|
Hyperplasia | 1 | 2016 | 148 | 0.040 |
Why?
|
Genetic Engineering | 1 | 2017 | 114 | 0.040 |
Why?
|
Atrophy | 1 | 2016 | 117 | 0.040 |
Why?
|
Patient Compliance | 1 | 2018 | 227 | 0.040 |
Why?
|
Interferon Type I | 1 | 2017 | 175 | 0.040 |
Why?
|
Syndrome | 1 | 2017 | 446 | 0.030 |
Why?
|
Child Health Services | 1 | 2016 | 49 | 0.030 |
Why?
|
Receptors, Leukotriene | 1 | 2015 | 10 | 0.030 |
Why?
|
Arachidonate 5-Lipoxygenase | 1 | 2015 | 22 | 0.030 |
Why?
|
Chicago | 1 | 2020 | 1379 | 0.030 |
Why?
|
Observational Studies as Topic | 1 | 2015 | 48 | 0.030 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2015 | 33 | 0.030 |
Why?
|
Phosphorylation | 2 | 2009 | 1106 | 0.030 |
Why?
|
Molecular Chaperones | 1 | 2015 | 111 | 0.030 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2015 | 113 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2017 | 337 | 0.030 |
Why?
|
Heat-Shock Proteins | 1 | 2015 | 179 | 0.030 |
Why?
|
Intestinal Neoplasms | 1 | 2014 | 56 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2014 | 131 | 0.030 |
Why?
|
Algorithms | 1 | 2001 | 1830 | 0.030 |
Why?
|
Mice, Transgenic | 1 | 2017 | 1540 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2016 | 455 | 0.030 |
Why?
|
Recurrence | 2 | 2005 | 1139 | 0.030 |
Why?
|
Guanidines | 1 | 2011 | 31 | 0.030 |
Why?
|
Enema | 1 | 2011 | 37 | 0.030 |
Why?
|
Defecation | 1 | 2011 | 23 | 0.030 |
Why?
|
Occludin | 1 | 2011 | 66 | 0.030 |
Why?
|
Autoimmune Diseases | 1 | 2014 | 241 | 0.030 |
Why?
|
Permeability | 1 | 2011 | 137 | 0.030 |
Why?
|
Zonula Occludens-1 Protein | 1 | 2011 | 70 | 0.030 |
Why?
|
Biological Transport | 1 | 2011 | 396 | 0.020 |
Why?
|
Colony Count, Microbial | 1 | 2010 | 46 | 0.020 |
Why?
|
Pain Management | 1 | 2011 | 127 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 3092 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2011 | 254 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2011 | 278 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2015 | 2818 | 0.020 |
Why?
|
Cell Degranulation | 1 | 2009 | 14 | 0.020 |
Why?
|
Disease Progression | 1 | 2014 | 1531 | 0.020 |
Why?
|
Arachidonic Acid | 1 | 2009 | 63 | 0.020 |
Why?
|
Models, Immunological | 1 | 2009 | 80 | 0.020 |
Why?
|
Phenotype | 1 | 2015 | 2378 | 0.020 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 113 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 115 | 0.020 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2009 | 213 | 0.020 |
Why?
|
Pouchitis | 1 | 2008 | 44 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2009 | 692 | 0.020 |
Why?
|
Mice | 2 | 2017 | 11352 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2017 | 6509 | 0.020 |
Why?
|
Bacteria | 1 | 2010 | 447 | 0.020 |
Why?
|
ZAP-70 Protein-Tyrosine Kinase | 1 | 2006 | 18 | 0.020 |
Why?
|
Vaginosis, Bacterial | 1 | 2006 | 8 | 0.020 |
Why?
|
Receptors, Immunologic | 1 | 2006 | 135 | 0.020 |
Why?
|
Cytomegalovirus Infections | 1 | 2006 | 144 | 0.020 |
Why?
|
Placebos | 1 | 2005 | 218 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2011 | 1196 | 0.020 |
Why?
|
Lymphoma | 1 | 2006 | 262 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2006 | 444 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2006 | 371 | 0.010 |
Why?
|
Base Sequence | 1 | 2006 | 2330 | 0.010 |
Why?
|
HLA Antigens | 1 | 2003 | 232 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2006 | 3030 | 0.010 |
Why?
|
Haplotypes | 1 | 2003 | 642 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2006 | 1384 | 0.010 |
Why?
|
Ion Transport | 1 | 1999 | 81 | 0.010 |
Why?
|
Logistic Models | 1 | 2003 | 1186 | 0.010 |
Why?
|
Electrophysiology | 1 | 1999 | 401 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2006 | 827 | 0.010 |
Why?
|
Hepatectomy | 1 | 1999 | 166 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2006 | 1920 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 1999 | 1047 | 0.010 |
Why?
|